Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Impact of quality of life of hydrendenties Suppurativa: A case Report

Congresso Regionale Fadoi Campania 2023 Cdc 231 (proceedings of XXII Congress of Fadoi Campania)
22 September 2023, Italy

Ciaburri F, Capasso F, Caruso G, Ferravante B, Olibet M, Sorrentino M, Vitolo G, Mattera A, D'Avino M

Impact on quality of life of Hidradenitis suppurativa: a case report
Long-Term Care Unit-Internal Medicine Department-AORN A. Cardarelli, Naples

Scientific Tracks Abstracts: Health Sci J

Abstract:

Background Hidradenitis suppurativa (HS) also known as acne inversa, is a chronic, recurrent, and debilitating inflammatory skin condition1, characterized by recurrent suppurative lesions leading to tissue destruction and fibrosis WHOSE prevalence is about 1% to 4%. We intend to demonstrate that this desease in actually underestimated and that it should be economically and socially supported by governments. Case History A 36 years old male with HS was transfered to our long term care Unit for urinary tract disease antibiotic treatment. Patient had poor socio-economic conditions. Before admittance to our ward he was hospitalized multiple times Patient history included: obesity cigarette heavy smoking ad suspected drug abuse, recurrent lung infections with lung failure and with pleuric empyiema complicated by hydro-pneumothorax, CKD, oftalmic and auditory infections with sight and hear loss monolaterally, hiatal hernia, gastropathy and bone fracture In 2019 first HS diagnosis was made during hospitalization for sepsis. Patient referred that first lesions apperared on upper limbs bilaterally, after bariatric surgery, while he was working abroad, and significantly improoved his economic conditions. Patient underestimated the importance of early diagnosis and kept working treating leasions as acne. In a few month lesions developed in perianal region and massive scar tissue persisted on the arms. Patient had to came back to Italy for medical care. He developed sepsis mutiple times and after his HS diagnosis was treated also with immunological therapy. He was never able to have a job again due to his poor clinical conditions and frequent hospitalizations and developed anxiety and mood disorders. At clinical examination, patient showed multiple lesions and abscesses in perianal region and referred perianal serous discharge. Other clinical condition were stable . After a few days of treatment patient developed chills and dysuria and presented ematochezia and anal purulent discharge. Blood tests showed inflamatory and septic indexes raise (Procalcitonin and C-reactive protein) and severe anemia. Patient underwent multiple blood transfusion in the next days. Subsequently patient referred emission of solid, malodorous material in urine associated with severe dysuria and ematuria. Surgical consult requested MRI that showed air in the bladder and the presence of multiple perianal fistulas . CT scan with contrast of pelvis that showed in detail one fistula between the posterior wall of the bladder and rectum.Discussion From data analysis in the literature, it emerges that the seriousness and consequent economic impact of the disease is underestimated. Therefore, in our opinion, economic as well as social support measures should be implemented by the Sanitary Service, in order to improve the quality and life expectancy of these patients